Estimation of the influence of photobiomodulation on the endothelial function in patients with arterial hypertension under the conditions of hyperuricemia

Keywords: hypertension, hyperuricemia, endothelial dysfunction, photobiomodulation, intravenous laser therapy

Abstract

Introduction. In 2015, the global prevalence of hypertension in the world was estimated at 1.13 billion.
The European Association for the Treatment of Hypertension (ESH) updated its recommendations in 2018 and
officially added to the already existing risk factors of hypertension hyperuricemia. In patients with comorbidity
of hyperuricemia and hypertension, endothelial dysfunction is observed.
The aim of the study is to establish correlation between uric acid level and pulse wave velocity, Tei index,
endothelium-dependent vasodilation of the brachial artery and evaluate the effect of photobiomodulation on
endothelial dysfunction in patients with hypertension.
Materials and methods. The study included 102 patients with hypertension: 48 without hyperuricemia
(group 1) and 54 with comorbidity of hypertension and hyperuricemia (group 2). Groups 1A and 2A received antihypertensive
therapy. Groups 1B and 2B — antihypertensive therapy with a course of intravenous laser therapy
with a wavelength of 635 nm, course 10 procedures. Endothelium-dependent vasodilation of the brachial artery
was determined by a breakdown with reactive hyperemia. Tei index was calculated during echocardiography.
The pulse wave velocity was measured with a SonoScape S6 Pro.
Results. Antihypertensive therapy in group 1A reduced the rate of the pulse wave by 7.8 %. Antihypertensive
therapy and intravenous laser therapy in Group 1 reduced uric acid by 5.7 %, pulse rate by 12.2 %, Tei index by
9.5 %, increased endothelium dependent vasodilation of the brachial artery by 19.1 % (p < 0,05). Antihypertensive
therapy in Group 2A reduced uric acid by 4.7 %, pulse rate by 8.5 % and increased endothelium-dependent
brachial artery vasodilation by 31.7 %. Combined use of antihypertensive therapy and intravenous laser therapy
in group 2B reduced uric acid by 19.2 %, pulse wave speed by 21.9 %, Tei index by 29.0 %, increased endothelium-
dependent vasodilation of the brachial artery by 97.7 % < 0.05). A correlation was established between
uric acid level and endothelium dependent vasodilation of the brachial artery r = - 0.62 (p < 0.001) and between
uric acid level and pulse wave velocity r = + 0.68, uric acid level and systolic blood pressure (day ) r = + 0.48
(p < 0.001), uric acid level and Tei index r = + 0.47 (p < 0.05).
Conclusion. Given the established negative correlation between the mean strength between uric acid
level and endothelium-dependent vasodilation of the brachial artery, it is appropriate to use in clinical practice
a combination of antihypertensive therapy with intravenous laser therapy, which significantly reduces the level
of uterine fibrillation hypertension and in patients with comorbidity of hypertension and hyperuricemia.
Key words: hypertension, hyperuricemia, endothelial dysfunction, photobiomodulation, intravenous
laser therapy.

Downloads

Download data is not yet available.

References

Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan

MJ, et al. Worldwide trends in blood pressure from

to2015: a pooled analysis of 1479 population-based

measurement studies with 19·1 million participants.

Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/

S0140-6736(16)31919-5 Available from: https://www.

ncbi.nlm.nih.gov/pmc/articles/PMC5220163/

Williams B, Mancia G, Spiering W, Agabiti Rosei E,

Azizi M, Burnier M et al. 2018 Practice Guidelines for

the management of arterial hypertension of the European

Society of Hypertension and the European Society of

Cardiology: ESH/ESC Task Force for the Management of

Arterial Hypertension. J Hypertens. 2018;36(12):2284-

doi: 10.1097/HJH.0000000000001961. Available

from: https://www.ncbi.nlm.nih.gov/pubmed/30380928

Tomiyama H, Shiina K, Vlachopoulos C, Iwasaki Y,

Matsumoto C, Kimura K et al. Vlachopoulos, et al.

Involvement of Arterial Stiffness and Inflammation in

Hyperuricemia-Related Development of Hypertension

Hypertension. 2018 Sep;72(3):739-745. doi: 10.1161/

HYPERTENSIONAHA.118.11390

Han, C., Xian, Z., Zou Y et al. Flow-mediated dilation

can be used to predict incident hypertension in patients

with hyperuricemia. Archives of Medical Science 2019

Mar;15(2):343-349. doi: 10.5114/aoms.2018.73856.

Available from: https://www.ncbi.nlm.nih.gov/

p u b m e d / ? t e r m = V l a c h o p o u l o s % 2 C + e t + a l . + I n -

volvement+of+Arterial+Stiffness+and+Inflammation+

in+Hyperuricemia-Related+Development+of+Hypertension

Tham EB, Silverman NH. Measurement of the Tei index:

a comparison of M-mode and pulse Doppler methods.

Journal of the American Society of Echocardiography.

December Volume 17 Issue 12 Pages 1259-1265.

Available from: https://www.ncbi.nlm.nih.gov/pubmed/?

term=Measurement+of+the+Tei+index%3A+a+-

comparison+of+M-mode+and+pulse+Doppler+methods

Ramirez, AJ, Christen, AI, Sanchez RA. Serum uric acid

elevation is associated to arterial stiffness in hypertensive

patients with metabolic disturbances. Curr. Hypertens

Rev. 2018;14(2):154-160. doi: 10.2174/1573402114

Available from: cbi.nlm.nih.gov/

pubmed/?term=).+Serum+Uric+Acid+Elevation+Is+Associated+

To+Arterial+Stiffness+In+Hypertensive+Patients+

With+Metabolic+Disturbances

Gu J, Fan YQ, Zhang HL, Zhang JF, Wang CQ. Serum

uric acid is associated with incidence of heart failure

with preserved ejection fraction and cardiovascular

events in patients with arterial hypertension. J Clin Hypertens.

; 20:560–567. https://doi.org/10.1111/

jch.13210. Available from: https://www.ncbi.nlm.

nih.gov/pubmed/?term=Serum+uric+acid+is+associated+

with+incidence+of+heart+failure+with+pres

e r v e d + e j e c t i o n + f r a c t i o n + a n d + c a r d i o v a s c u -

lar+events+in+patients+with+arterial+hypertension

Helms CC, Liu X, Kim-Shapiro DB. Recent insights

into nitrite signaling processes in blood. Biol Chem.

;398(3):319–329. doi:10.1515/hsz-2016-0263

Available from: https://www.ncbi.nlm.nih.gov/

pubmed/27611767

Wajih N, Basu S, Ucer KB, et al. Erythrocytic bioactivation

of nitrite and its potentiation by far-red light. Redox Biol.;

:442–450. doi:10.1016/j.redox. 2018.11.001

Wajih N, Basu S, Ucer K.B, Rigal F, Shakya A, Rahbar

E. Pathophysiology of circulating xanthine oxidoreductase:

New emerging roles for a multi-tasking enzyme,

Biochimica et Biophysica Acta (BBA) -Molecular

Basis of Disease,Volume1842, Issue 9,2014, Pages

-1517, ISSN 0925-4439,https://doi.org/10.1016/j.

bbadis.2014.05.022. Available from: https://www.ncbi.

nlm.nih.gov/pubmed/?term=Erythrocytic+bioactivation+

of+nitrite+and+its+potentiation+by+far-red+light

Published
2020-01-13
How to Cite
Коваленко, Є. Л., МелеховецьO. K., & Мелеховець, Ю. В. (2020). Estimation of the influence of photobiomodulation on the endothelial function in patients with arterial hypertension under the conditions of hyperuricemia. Photobiology and Photomedicine, (28), 9-15. https://doi.org/10.26565/2076-0612-2019-28-01
Section
Clinical photomedicine